Nikhil Patel, founder of Craniometrix, wants to fight Alzheimer’s. The company is setting up a telemedicine platform aimed specifically at treating the disease.
But why does Nikhil Patel want to create such a platform? In fact, Mr Patel himself has had painful memories of the condition. In his youth, he could only watch his grandmother, who had it, gradually lose ground. Despite his age, the young man understood that the premature detection and treatment could delay the onset of dementia. So Mr Patel has made it a goal, for himself and for his company, Craniometrix.
A kind of game to spot Alzheimer’s disease
Craniometrix counts among its members scientists who come at Yale et the Harvard. This team totals more than 40 years of studies on Alzheimer’s disease. As for the founder, Nikhil Patel, he studied computer science at Yale. Together, these scientists are working to provide patients with a service available at all hours7 j/7.
The first step of this project is to allow those who are worried about self-diagnose from home. To do this, the person only has to perform ten minutes of play on his smartphone. Obviously, the services that Craniometrix wants to offer are more than technological.
Following this test, doctor in connection with the company deals to examine et to check the diagnostics of the platform. Craniometrix promises to send the patient a report about his test about Alzheimer’s disease in 48 hours. According to Mr Patel, this method can detect disease several years even before symptoms appear.
The ability to spot Alzheimer’s cases so early is very encouraging. However, Craniometrix wants to go even further. He wants his customers to be able to consult a doctor in real time. This service targets those who have questions about the report they have received.
In addition, the company also intends to create bundled monthly subscriptions. These subscriptions include one-time screenings and the service mentioned above. Added to this are several other tools for manage symptoms et support caregivers.
An interesting vision for investors
Thus, Craniometrix aims to enable the early detection of Alzheimer’s disease. In addition to speak directly to their customersits services offer a assistance continue.
“Many of today’s visits could easily be made through a chat service or an offline communication service. »
Nikhil Patel
In other words, this platform aims to reduce the need to go to a doctor’s office. Eventually, Mr Patel believes it may even eliminate this need to treat Alzheimer’s disease.
With this project, Nikhil Patel and his team have managed to bring together 6 million dollars. These funds will be used to initiate an application in accordance with la Health Insurance Portability and Accountability Act ou HIPAA.
Note that J Ventures, Quiet Capital, Cathexis Ventures, Olive Tree Capital, Defy.vc and Rebel Fund are among the Craniometrix investors. They bet on the founder as well as its broader ambitions. The design of a one-stop telemedicine platform is the main example.